Table 2.
Wnt3a | Wnt5a | β-catenin | MMP-9 | VEGFR-2 | |
---|---|---|---|---|---|
Primary tumor |
51 (61.4%) |
58 (69.9%) |
70 (84.3%) |
45 (54.2%) |
30 (36.1%) |
Metastatic site |
38 (45.8%) |
39 (47.0%) |
44 (53.0%) |
28 (33.7%) |
22 (26.5%) |
Concordance rate | 79.4% | 76.2% | 79.4% | 68.3% | 40.0% |